• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Sun Pharma receives USFDA approval for generic Strattera capsules

      Posted AtIbtimes.com

      Sun Pharma, a speciality pharmaceuticals and active pharmaceutical ingredients maker, has recieved US Food and Drug Administration (USFDA) for its subsidiary an approval for its abbreviated new drug application to market a generic version of Strattera, Atomoxetine hydrochloride capsules.

      These generic atomoxetine hydrochloride capsules are equivalent to Eli Lilly’s Strattera capsules and include six strengths: 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, and 100 mg.

      Annual sale in U.S. for these strengths of branded and generic atomoxetine hydrochloride capsules is estimated at over $530 million.

      Atomoxetine Hydrochloride capsules are used for the treatment of attention deficit hyperactivity disorder in children aged 6 and older, teens and adults.

      The company receives 180 days marketing exclusivity for this drug.

      The company manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.

      In India, the company is a leader in niche therapy areas of psychiatry, neurology, cardiology, diabetology, gastroenterology, orthopedics and ophthalmology.

      The USFDA issued a warning letter to Sun Pharma for violations in current good manufacturing practice regulation at its Cranbury facility in New Jersey. USFDA has withheld approval of pending new drug applications listing the facility as the manufacturer, Sun Pharma said in a statement on Tuesday.

      It has also recieved USFDA’s approval to a generic version of Venlafaxine Hydrochloride Extended Release tablets.

      On Wednesday, the company's shares were down by 0.80 percent at 1,746.00 rupees.

      Sep 07, 2010


       

      Share this Article!

    Back to top^